Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: Two case reports

Clinical Neuropharmacology

Volumn 24, Issue 6, 2001, Pages 358-360

  Takahashi, Hitoshi ^a   Yoshida, Keizo ^a   Higuchi, Hisashi ^a   Shimizu, Tetuo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbamazepine; Parkinsonian symptoms; Risperidone

Indexed keywords

CARBAMAZEPINE; DONEPEZIL; PLACEBO; RISPERIDONE;

ADULT; AGED; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; DEMENTIA; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG METABOLISM; DRUG WITHDRAWAL; HUMAN; MALE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; DRUG INTERACTIONS; HUMANS; MALE; PARKINSON DISEASE, SECONDARY; RISPERIDONE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035196511     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200111000-00008     Document Type: Article

References (11)

1. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition
2. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels
3. Serum concentrations and side effects in psychiatric patients during risperidone therapy
4. Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate
5. Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity
6. Risperidone use at a state hospital: A clinical audit 2 years after the first wave of risperidone prescriptions
7. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia
8. Antipsychotic treatment of psychosis and agitation in the elderly
9. The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses
10. Treatment of aggression in patients with bipolar disorder
11. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia